Advanced in Hepatitis C

Dr. Vilma S. Drelichman

Infectious Disease
32255 Northwestern Hwy, Suite 160, 
Farmington Hills, MI 
Accepting New Patients
Advanced in Hepatitis C
32255 Northwestern Hwy, Suite 160, 
Farmington Hills, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Vilma Drelichman is an Infectious Disease provider in Farmington Hills, Michigan. Dr. Drelichman is rated as an Advanced provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are Cellulitis, Myelitis, Multisystem Inflammatory Syndrome in Children (MIS-C), and COVID-19. Dr. Drelichman is currently accepting new patients.

Her clinical research consists of participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Infectious Disease
Licenses
Internal Medicine in MI
Languages Spoken
English
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MetLife
  • PPO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

32255 Northwestern Hwy, Suite 160, Farmington Hills, MI 48334

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase I/II, Observer-blind, Randomised, Placebo-controlled Study to Assess Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)
A Phase I/II, Observer-blind, Randomised, Placebo-controlled Study to Assess Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)
Enrollment Status: Completed
Publish Date: May 08, 2025
Intervention Type: Biological
Study Phase: Phase 2
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Study Drugs: Cabotegravir, Rilpivirine, BIKTARVY
Study Phase: Phase 3
View 1 Less Clinical Trial
Similar Doctors
Distinguished in Hepatitis C
Dr. Paul J. Chittick
Infectious Disease
Distinguished in Hepatitis C
Dr. Paul J. Chittick
Infectious Disease

Beaumont Medical Group- Specialty Services

3601 W 13 Mile Rd, 
Royal Oak, MI 
 (8.0 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Paul Chittick is an Infectious Disease provider in Royal Oak, Michigan. Dr. Chittick is rated as an Advanced provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, COVID-19, and Multisystem Inflammatory Syndrome in Children (MIS-C). Dr. Chittick is currently accepting new patients.

Advanced in Hepatitis C
Dr. Tania B. Little
Infectious Disease
Advanced in Hepatitis C
Dr. Tania B. Little
Infectious Disease

Ascension St John Hospital

31500 Telegraph Rd, Suite 225, 
Bingham Farms, MI 
 (3.3 miles away)
248-552-0620
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Tania Little is an Infectious Disease provider in Bingham Farms, Michigan. Dr. Little is rated as an Advanced provider by MediFind in the treatment of Hepatitis C. Her top areas of expertise are Hepatitis C, Hepatitis, Chronic Inflammatory Response Syndrome (CIRS), and Myelitis. Dr. Little is currently accepting new patients.

Advanced in Hepatitis C
Dr. Jehad Sibai
Infectious Disease
Advanced in Hepatitis C
Dr. Jehad Sibai
Infectious Disease

Bishr Ujayli MD PC

11800 E 12 Mile Rd, Ascension St John Macomb, 
Warren, MI 
 (17.6 miles away)
586-573-5000
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients

Jehad Sibai is an Infectious Disease provider in Warren, Michigan. Dr. Sibai is rated as a Distinguished provider by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hospital-Acquired Pneumonia, Pneumonia, Lymphangitis, and Osteomyelitis. Dr. Sibai is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Drelichman's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 17 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile